Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc

10 Cathie Wood Stocks Insiders are Selling

Natera (NTRA) Rose on Momentum in the Oncology Market

Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)

CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications

Insider Sell: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

TipRanks’ ‘Perfect 10’ List: Analysts See Opportunity in These 2 Top-Scoring Stocks

Estimating The Fair Value Of Natera, Inc. (NASDAQ:NTRA)

Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation

Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients

Here are Friday's biggest analyst calls: Apple, Tesla, Netflix, Marvell, Ollie's, Snowflake, Eli Lilly, Krispy Kreme & more

Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer

Is Natera (NTRA) On The Cusp Of Being Cash Flow Positive?

Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)

Here are the top investment ideas out of the Sohn conference, including an e-commerce play

Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer

Will Natera (NTRA) Continue to Deliver Solid Topline Growth?

Genetic Testing Stock Nears Buy Point After Earnings Gap-Up And 45% Gain

Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer